The gonadotropin hormone receptors, including the follicle-stimulating hormone receptor (FSHR) and the luteinizing hormone/choriogonadotropin receptor (LH/CGR), serve as integral mediators of ...
CDK 4/6 inhibitors (CDK4/6i) remain part of the standard first-line treatment for patients with hormone receptor–positive metastatic breast cancer, offering demonstrable improvements in both ...
A team of scientists has made an important discovery that could lead to a novel treatment for obesity and obesity-associated diseases or conditions. Texas A&M AgriLife Research study may lead to novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results